United Kingdom - English - VMD (Veterinary Medicines Directorate)

laboratorios hipra sa - chorionic gonadotrophin, serum gonadotrophin - lyophilisate and solvent for solution for injection - hormone sex - pigs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

ceva animal health ltd - chorionic gonadotrophin, serum gonadotrophin - powder and solvent for solution for injection - hormone sex - pigs

Australia - English - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - lutropin alfa, quantity: 75 iu - injection, powder for - excipient ingredients: methionine; sodium hydroxide; phosphoric acid; sucrose; polysorbate 20; dibasic sodium phosphate dihydrate; monobasic sodium phosphate monohydrate - luveris in association with a recombinant follicle stimulating hormone (fsh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh of less than 1.2 iu/l.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - ifosfamide, quantity: 2 g - injection, powder for - excipient ingredients: - use in the treatment of tumours sensitive to ifosfamide either as a single agent or in combination with other chemotherapeutic agents. tumour types that have been demonstrated to respond to ifosfamide single agent or in combination are germ cell tumours, sarcomas, lymphomas. anti-tumour activity has been shown in ovarian and cervical cancers. some activity has also been seen in lung and breast cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - ifosfamide, quantity: 1 g - injection, powder for - excipient ingredients: - use in the treatment of tumours sensitive to ifosfamide either as a single agent or in combination with other chemotherapeutic agents. tumour types that have been demonstrated to respond to ifosfamide single agent or in combination are germ cell tumours, sarcomas, lymphomas. anti-tumour activity has been shown in ovarian and cervical cancers. some activity has also been seen in lung and breast cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - medroxyprogesterone acetate, quantity: 150 mg/ml - injection, suspension - excipient ingredients: propyl hydroxybenzoate; methyl hydroxybenzoate; water for injections; sodium chloride; macrogol 3350; polysorbate 80 - carcinoma: palliative treatment of recurrent and/or metastatic breast or renal cell cancer and of inoperable recurrent or metastatic endometrial carcinoma. endometriosis: for use in the treatment of visually proven (laparoscopy) endometriosis where the required end-point of treatment is pregnancy, or for the control of symptoms when surgery is contra- indicated or has been unsuccessful. contraception (ovulation suppression): for long-term prevention of pregnancy in women when administered at 3-month intervals. since loss of bone mineral density (bmd) may occur in pre-menopausal women who use depo-provera long-term (greater than 2 years), women should be assessed, before starting treatment for contraception or endometriosis, regarding the risk of osteoporosis. women under the age of 18 years may be at risk of failing to achieve their predicted peak bone mineral density (see warnings). the 50 mg/1ml vial is not approved for the indication of contraception (ovulation suppression). the injection, depo-provera 1

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bsv bioscience malaysia sdn. bhd. - chorionic gonadotrophin -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vaccifar b.v. - gonadotrophin serum (pmsg) 400 iu/dose; chorionic gonadotrophin (hcg) 1000 iu/dose - powder for solution for injection - chorionic gonadotrophin; qg03ga99 gonadotropins, combinations; qg03ga03 serum gonadotrophin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vaccifar b.v. - gonadotrophin serum (pmsg) 400 iu/dose; chorionic gonadotrophin (hcg) 1000 iu/dose - powder for solution for injection - chorionic gonadotrophin; qg03ga99 gonadotropins, combinations; qg03ga03 serum gonadotrophin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vaccifar b.v. - gonadotrophin serum (pmsg) 400 iu/dose; chorionic gonadotrophin (hcg) 200 iu/dose - powder and solvent for solution for injection - chorionic gonadotrophin; qg03ga99 gonadotropins, combinations; qg03ga03 serum gonadotrophin